Latest Insider Transactions at Ligand Pharmaceuticals Inc (LGND)
This section provides a real-time view of insider transactions for Ligand Pharmaceuticals Inc (LGND). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LIGAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LIGAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2024
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
2,000
-8.15%
|
$198,000
$99.6 P/Share
|
|
Sep 23
2024
|
Andrew Reardon CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.54%
|
$104,000
$52.27 P/Share
|
|
Sep 23
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
9,772
-5.57%
|
$986,972
$101.24 P/Share
|
|
Sep 23
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,772
+7.09%
|
$498,372
$51.42 P/Share
|
|
Sep 20
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
6,275
-11.0%
|
$652,600
$104.1 P/Share
|
|
Sep 20
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,982
+8.03%
|
$244,118
$49.99 P/Share
|
|
Sep 20
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,275
-1.66%
|
$131,325
$103.93 P/Share
|
|
Sep 17
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,486
+2.73%
|
$101,048
$68.97 P/Share
|
|
Sep 16
2024
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,214
-1.53%
|
$337,470
$105.0 P/Share
|
|
Sep 16
2024
|
Matthew E Korenberg President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,774
+2.64%
|
$323,344
$56.29 P/Share
|
|
Aug 28
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
753
+1.52%
|
$47,439
$63.63 P/Share
|
|
Aug 28
2024
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,500
-6.24%
|
$159,000
$106.39 P/Share
|
|
Aug 28
2024
|
Andrew Reardon CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.87%
|
$78,000
$52.27 P/Share
|
|
Aug 26
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
11,389
-9.83%
|
$1,195,845
$105.67 P/Share
|
|
Aug 23
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
6,312
-4.8%
|
$656,448
$104.61 P/Share
|
|
Aug 22
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
1,157
-1.69%
|
$121,485
$105.54 P/Share
|
|
Aug 09
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
18,245
-21.07%
|
$1,788,010
$98.5 P/Share
|
|
Aug 08
2024
|
Todd C Davis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+1.99%
|
$242,500
$97.39 P/Share
|
|
Jun 28
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
267
+1.12%
|
$16,020
$60.71 P/Share
|
|
Jun 28
2024
|
Matthew E Korenberg President & COO |
BUY
Other acquisition or disposition
|
Direct |
350
+0.4%
|
$21,000
$60.71 P/Share
|
|
Jun 28
2024
|
Andrew Reardon CLO & Secretary |
BUY
Other acquisition or disposition
|
Direct |
329
+1.44%
|
$19,740
$60.71 P/Share
|
|
Jun 28
2024
|
Todd C Davis Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
350
+0.29%
|
$21,000
$60.71 P/Share
|
|
Jun 14
2024
|
Stephen L Sabba Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+3.98%
|
-
|
|
Jun 14
2024
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+1.58%
|
-
|
|
Jun 14
2024
|
Nancy Ryan Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+15.39%
|
-
|
|
Jun 14
2024
|
Jason Haas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+18.83%
|
-
|
|
Jun 14
2024
|
John W Kozarich Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+2.78%
|
-
|
|
Jun 14
2024
|
John L Lamattina Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+4.07%
|
-
|
|
Jun 14
2024
|
Martine Zimmermann Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+26.14%
|
-
|
|
May 17
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,156
-9.08%
|
$443,416
$86.66 P/Share
|
|
May 17
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,917
+5.68%
|
$415,020
$60.61 P/Share
|
|
May 16
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,264
-9.48%
|
$194,704
$86.0 P/Share
|
|
May 15
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,873
-19.74%
|
$505,078
$86.01 P/Share
|
|
May 14
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
14,158
-7.09%
|
$1,203,430
$85.38 P/Share
|
|
May 13
2024
|
Matthew E Korenberg President & COO |
SELL
Open market or private sale
|
Direct |
3,440
-3.31%
|
$288,960
$84.54 P/Share
|
|
May 09
2024
|
Nancy Ryan Gray Director |
SELL
Open market or private sale
|
Direct |
934
-14.22%
|
$77,522
$83.2 P/Share
|
|
May 09
2024
|
Andrew Reardon CLO & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-31.05%
|
$830,000
$83.04 P/Share
|
|
May 09
2024
|
Andrew Reardon CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.69%
|
$520,000
$52.27 P/Share
|
|
Apr 30
2024
|
Jason Aryeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,406
+3.04%
|
$125,112
$52.3 P/Share
|
|
Apr 24
2024
|
John W Kozarich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,893
+6.37%
|
$112,827
$39.35 P/Share
|
|
Mar 25
2024
|
Todd C Davis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,015
+3.35%
|
$992,930
$62.04 P/Share
|
|
Mar 05
2024
|
Stephen L Sabba Director |
SELL
Open market or private sale
|
Direct |
1,893
-6.14%
|
$140,082
$74.3 P/Share
|
|
Mar 05
2024
|
Stephen L Sabba Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,893
+8.58%
|
-
|
|
Mar 05
2024
|
Jason Aryeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,893
+3.74%
|
$112,827
$39.35 P/Share
|
|
Feb 28
2024
|
Octavio Espinoza Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
140
-0.47%
|
$12,320
$88.46 P/Share
|
|
Feb 28
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,264
+1.4%
|
$72,048
$57.15 P/Share
|
|
Feb 27
2024
|
Todd C Davis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,436
+23.75%
|
-
|
|
Feb 27
2024
|
Octavio Espinoza Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,208
+20.11%
|
-
|
|
Feb 27
2024
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,416
+12.19%
|
-
|
|
Feb 27
2024
|
Andrew Reardon CLO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,208
+24.51%
|
-
|